Ticker >

Natural Capsules share price

Natural Capsules Ltd.

BSE: 524654 SECTOR: Pharmaceuticals & Drugs  16k   59   3

334.05
0 0
BSE: 23 Feb 04:01 PM

Price Summary

Today's High

₹ 342.7

Today's Low

₹ 330.05

52 Week High

₹ 512

52 Week Low

₹ 330

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

312.31 Cr.

Enterprise Value

359.21 Cr.

No. of Shares

0.93 Cr.

P/E

32.91

P/B

2.41

Face Value

₹ 10

Div. Yield

0.3 %

Book Value (TTM)

₹  138.86

CASH

2.25 Cr.

DEBT

49.16 Cr.

Promoter Holding

56.56 %

EPS (TTM)

₹  10.15

Sales Growth

27.99%

ROE

18.54 %

ROCE

20.5%

Profit Growth

37.58 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Natural Capsules Ltd.

Veenat Lenalid Erlonat Geftinat Sorafenat Bortenat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year27.99%
3 Year41.09%
5 Year25.85%

Profit Growth

1 Year39.09%
3 Year181.52%
5 Year76.69%

ROE%

1 Year18.54%
3 Year16.52%
5 Year10.92%

ROCE %

1 Year20.5%
3 Year19.33%
5 Year13.24%

Debt/Equity

0.3963

Price to Cash Flow

15.53

Interest Cover Ratio

7.63970702016815

CFO/PAT (5 Yr. Avg.)

0.939527820126712

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 56.56 0
Sep 2023 56.56 0
Jun 2023 56.56 0
Mar 2023 56.56 0
Dec 2022 56.56 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 181.839176191064% for the Past 3 years.
  • The company has shown a good revenue growth of 41.0855782467289% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -3.77890929207319 days.
  • The company has a high promoter holding of 56.56%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.7651328712911.

 Limitations

  • Company has contingent liabilities of 97.2283 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 45.5 38.12 37.7 37.52 38.38
Total Expenditure 35.8 31.24 31.64 32.27 33.44
Operating Profit 9.7 6.88 6.06 5.25 4.94
Other Income 0.01 0.81 0.58 0.6 0.71
Interest 0.95 1.27 1.21 1.15 1.2
Depreciation 1.74 1.86 2.11 2.16 2.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 7.02 4.56 3.32 2.54 2.29
Tax 1.77 1.2 0.86 0.57 0.59
Profit After Tax 5.25 3.36 2.46 1.97 1.7
Adjusted EPS (Rs) 5.68 3.62 2.65 2.11 1.82

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 59.78 61.55 79.51 135.07 172.87
Total Expenditure 54.73 56.11 68.38 110.66 138.17
Operating Profit 5.05 5.45 11.14 24.41 34.7
Other Income 1.14 0.95 0.73 2.14 2.12
Interest 0.53 0.91 0.54 2.08 3.88
Depreciation 3.2 4.12 4.31 5.04 7.2
Exceptional Items -0.39 0 2.18 0 0
Profit Before Tax 2.07 1.37 9.19 19.43 25.74
Tax 0.15 0.51 2.24 5.47 6.55
Net Profit 1.92 0.86 6.88 13.76 19.13
Adjusted EPS (Rs.) 2.53 1.13 9.14 19.9 20.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.23 6.23 6.23 7.01 9.28
Total Reserves 49.26 49.39 55.9 76.04 114.78
Borrowings 0 0 0 14.75 23.01
Other N/C liabilities 1.23 1.08 1.55 2.28 3.18
Current liabilities 16.42 17.98 32.98 43.41 60.15
Total Liabilities 73.15 74.68 96.66 143.49 210.4
Assets
Net Block 24.37 23.81 34.59 62.94 93.22
Capital WIP 2.45 2.11 3.45 1.07 0
Intangible WIP 0 0 0 0 0
Investments 5.08 5.58 0.02 0.05 20.01
Loans & Advances 2.09 4.69 1.47 21.6 21.52
Other N/C Assets 0.81 0.79 0.78 0.41 1
Current Assets 38.35 37.7 56.35 57.42 74.65
Total Assets 73.15 74.68 96.66 143.49 210.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 2.07 1.37 9.19 19.43 25.74
Adjustment 3.89 5.03 2.73 6.33 9.9
Changes in Assets & Liabilities -3.07 1.46 -3.91 -15.92 -10.08
Tax Paid -0.79 -0.66 -2.22 -4.74 -5.46
Operating Cash Flow 2.1 7.2 5.78 5.09 20.11
Investing Cash Flow -7.06 -5.74 -8.54 -30.42 -55.42
Financing Cash Flow 4.28 -1.19 2.52 26.51 34.44
Net Cash Flow -0.68 0.27 -0.24 1.18 -0.87

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 56.56 56.56 56.56 56.56 56.56
chandra rameshwar laddha 0.01 0.01 0.01 0.01 0.01
indra mundra 4.19 4.19 4.19 4.19 4.19
jyoti mundra 3.28 3.28 3.28 3.28 3.28
jyotsna daga 0.40 0.40 - 0.40 0.40
laxminarayan moondra 2.57 2.57 2.57 2.57 2.57
madhav mundra 1.77 1.77 1.77 1.77 1.77
mukund gattani 0.01 0.01 0.01 0.01 0.01
nandi synthetics pvt ltd 9.83 9.83 9.83 9.83 9.83
nidhi sethia 0.20 0.20 0.20 0.20 0.20
radha s mundra 2.56 2.56 2.56 2.56 2.56
satyanarayan mundra 1.98 1.98 1.98 1.98 1.98
sharada mundra 2.83 2.83 2.83 2.83 2.83
shrey mundra 1.77 1.77 1.77 1.77 1.77
sunil laxminaryan mundra 6.30 6.30 6.30 6.30 6.30
sushil kumar mundra 5.44 5.44 5.44 5.44 5.44
tajos investments private... 13.41 13.41 13.41 13.41 13.41
jyotsna daga - - 0.40 - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 43.44 43.44 43.44 43.44 43.44
india equity fund 1 1.31 1.31 1.31 1.31 1.31
investor education and pr... - - - - 1.23
sangeetha s 3.50 3.50 3.50 - 3.50
vivog commercial limited 2.07 1.98 1.93 - 1.67
investor education and pr... - 1.17 1.17 1.17 -
sangeeta s - - - 3.50 -
viviog commercial limited... - - - 1.67 -
prabha mohta 1.44 1.44 - - -
r pattabiraman 2.98 2.98 - - -
investor education and pr... 1.17 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • ConcallQ2FY24 27 Nov 2023
  • PresentationQ4FY23 31 May 2023
  • PresentationQ3FY24 12 Feb 2024
  • PresentationQ3FY23 11 Apr 2023

Company News

Natural Capsules - Quaterly Results9 Feb 2024, 5:53PM Natural Capsules - Quaterly Results9 Feb 2024, 5:53PM Natural Capsules informs about loss of share certificate18 Jan 2024, 11:43AM Natural Capsules informs about press release10 Nov 2023, 10:15AM Natural Capsules, its arm enter into agreement with O2 Renewable Energy VIII, O2 Energy SG Pte30 Sep 2023, 4:58PM Natural Capsules’ arm inaugurates small volume production, R&D blocks21 Sep 2023, 6:09PM Natural Capsules informs about details of loss of certificate14 Sep 2023, 4:24PM Natural Capsules informs about newspaper publication17 Aug 2023, 5:19PM Natural Capsules informs about investor presentation10 Aug 2023, 10:24AM Natural Capsules - Quaterly Results9 Aug 2023, 7:02PM Natural Capsules - Quaterly Results9 Aug 2023, 7:02PM Natural Capsules informs about summary of proceedings28 Jul 2023, 4:33PM Somerset Indus Capital Partners makes investment in Natural Capsules’ arm 22 Jun 2023, 4:10PM Natural Capsules informs about earnings conference call3 Jun 2023, 1:36PM Natural Capsules informs about details of loss of certificate 3 May 2023, 3:11PM Natural Capsules informs about annual disclosure28 Apr 2023, 4:25PM Natural Capsules informs about loss of share certificate22 Apr 2023, 12:02PM Natural Capsules informs about details of loss of certificate28 Feb 2023, 4:13PM Natural Capsules - Quaterly Results13 Feb 2023, 6:01PM Natural Capsules - Quaterly Results13 Feb 2023, 6:01PM Natural Capsules informs about trading window closure29 Dec 2022, 3:03PM Natural Capsules’ arm completes maiden fund raise of Rs 18.75 crore21 Nov 2022, 5:15PM Natural Capsules - Quaterly Results28 Oct 2022, 7:13PM Natural Capsules - Quaterly Results28 Oct 2022, 7:13PM Natural Capsules informs about board meeting 21 Oct 2022, 9:53AM Natural Capsules informs about meeting updates20 Sep 2022, 4:27PM Natural Capsules informs about outcome of AGM20 Sep 2022, 1:35PM Natural Capsules informs about loss of share certificate15 Sep 2022, 5:17PM Natural Capsules informs about loss of share certificate13 Sep 2022, 4:57PM Natural Capsules informs about newspaper cuttings12 Aug 2022, 10:26AM Natural Capsules informs about loss of his share certificate28 Jul 2022, 5:02PM Natural Capsules informs about compliances-certificate16 Jul 2022, 4:44PM Natural Capsules informs about loss of share certificate29 Jun 2022, 3:34PM Natural Capsules informs about details of loss of certificate23 Jun 2022, 4:13PM Natural Capsules - Quaterly Results9 May 2022, 7:46PM Natural Capsules - Quaterly Results9 May 2022, 7:46PM Natural Capsules informs about non-applicability of large corporate entity28 Apr 2022, 4:41PM Natural Capsules informs about certificate18 Apr 2022, 5:04PM Natural Capsules informs about analyst meet7 Apr 2022, 2:39PM Natural Capsules - Quaterly Results8 Feb 2022, 6:07PM Natural Capsules - Quaterly Results8 Feb 2022, 6:07PM Natural Capsules informs about clarification9 Dec 2021, 4:58PM Natural Capsules informs about certificate8 Oct 2021, 4:00PM Natural Capsules informs about analyst meet22 Sep 2021, 4:17PM Natural Capsules informs about board meeting2 Aug 2021, 9:52AM Natural Capsules informs about outcome of AGM16 Jul 2021, 11:41AM Natural Capsules gets nod for capacity expansion plan 16 Jul 2021, 10:17AM Natural Capsules informs about compliance certificate12 Jul 2021, 1:05PM Natural Capsules informs about annual secretarial compliance report15 Jun 2021, 12:41PM Natural Capsules incorporates WOS company26 Aug 2020, 9:52AM

Natural Capsules Stock Price Analysis and Quick Research Report. Is Natural Capsules an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Natural Capsules and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natural Capsules cash from the operating activity was Rs 20.1067 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natural Capsules has a Debt to Equity ratio of 0.3963 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natural Capsules , the EPS growth was 4.00641186697888 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natural Capsules has OPM of 20.0734086123516 % which is a good sign for profitability.
     
  • ROE: Natural Capsules have a average ROE of 18.5394899547143 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Natural Capsules is Rs 334.05. One can use valuation calculators of ticker to know if Natural Capsules share price is undervalued or overvalued.
Last Updated on:
Brief about Natural Capsules
X